peripheral blood lymphocytes Report issue

Cell therapy Experimental
AACT

Active Ingredient History

NOW
  • Now
Blood is a body fluid in the circulatory system of humans and other vertebrates that delivers necessary substances such as nutrients and oxygen to the cells, and transports metabolic waste products away from those same cells.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

autologous pbmc | autologous pbmcs | autologous peripheral blood lymphocytes | autologous peripheral blood mononuclear cells | autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor | in vitro-treated peripheral blood lymphocyte | in vitro-treated peripheral blood stem cell | peripheral blood | peripheral blood cells | peripheral blood derived mononuclear cells | peripheral blood lymphocyte | peripheral blood lymphocytes | peripheral blood mononuclear cell | peripheral blood mononuclear cells | peripheral mononuclear cell

Organizations (61)

Research & Development (61)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (77)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (77)


 

Acne Vulgaris (Phase 2)

Allogeneic Cells (Phase 2)

Anemia, Aplastic (Phase 2)

Anemia, Neonatal (Phase 1)

Anemia, Sickle Cell (Phase 2)

Angina Pectoris (Phase 1/Phase 2)

Atherosclerosis (Phase 3)

Bone Marrow Diseases (Phase 1)

Brain Neoplasms (Phase 1)

Breast Neoplasms (Phase 2)

Bronchopulmonary Dysplasia (Phase 1)

Cartilage Diseases (Phase 2)

Cerebral Palsy (Phase 1/Phase 2)

Chest Pain (Phase 1/Phase 2)

Chronic Limb-Threatening Ischemia (Phase 3)

Coronary Artery Disease (Phase 1/Phase 2)

COVID-19 (Phase 1/Phase 2)

Decitabine (Phase 2)

Diabetic Foot (Phase 1/Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)

Enterocolitis, Necrotizing (Phase 1)

Enterocolitis, Neutropenic (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gangrene (Phase 3)

Gestational Trophoblastic Disease (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Gliosarcoma (Phase 1/Phase 2)

Graft vs Host Disease (Phase 2)

Granulocyte Colony-Stimulating Factor (Phase 1/Phase 2)

Hamartoma (Phase 2)

Healthy Volunteers (Phase 1)

Hematologic Diseases (Phase 2)

Hematologic Neoplasms (Phase 1/Phase 2)

Hematopoietic Stem Cell Transplantation (Phase 2)

Intestinal Neoplasms (Phase 1)

Intracranial Hemorrhages (Phase 1)

Ischemia (Phase 1/Phase 2)

Kidney Failure, Chronic (Phase 1/Phase 2)

Kidney Neoplasms (Phase 2)

Leg Ulcer (Phase 1/Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Leukocytes, Mononuclear (Phase 1/Phase 2)

Lung Neoplasms (Phase 2)

Lymphocytes (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 3)

Multiple Myeloma (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Myocardial Infarction (Phase 1/Phase 2)

Myocardial Ischemia (Phase 1/Phase 2)

Neoplasms (Phase 2)

Neuroblastoma (Phase 2)

Neurodegenerative Diseases (Phase 1/Phase 2)

Neutropenia (Phase 1)

Ovarian Neoplasms (Phase 2)

Pain (Phase 1/Phase 2)

Peripheral Blood Stem Cell Transplantation (Phase 2)

Peripheral Vascular Diseases (Phase 1/Phase 2)

Precancerous Conditions (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostheses and Implants (Phase 2)

Recurrence (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 1)

Retinoblastoma (Phase 3)

Retinopathy of Prematurity (Phase 1)

Sarcoma (Phase 2)

Testicular Neoplasms (Phase 2)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 73
  • # of Trial Organizations: 61

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue